[HTML][HTML] Amivantamab: A narrative drug review
A John, V Noronha, A Singh, N Menon… - Cancer Research …, 2023 - journals.lww.com
Epidermal growth factor receptor (EGFR) activating mutations are known oncogenic drivers
in non-small-cell lung cancer (NSCLC), with 85% attributable to an exon 19 deletion or exon …
in non-small-cell lung cancer (NSCLC), with 85% attributable to an exon 19 deletion or exon …
Clinical profile and outcomes of asymptomatic vs. symptomatic travellers diagnosed with COVID-19: An observational study from a coastal town in South India
Despite the high number of coronavirus disease-19 (COVID-19) cases from India, there are
few reports from India describing the clinical epidemiology of COVID-19. This study aimed to …
few reports from India describing the clinical epidemiology of COVID-19. This study aimed to …
[HTML][HTML] A Comparative Study Evaluating the Quality of Life and Survival Outcomes in Patients Receiving Chemotherapy Versus Oral Tyrosine Kinase Inhibitor in the …
Introduction The outcomes in advanced NSCLC have improved owing to the availability of
more effective systemic and improved supportive care. This has increased the number of …
more effective systemic and improved supportive care. This has increased the number of …
A comparative study evaluating the quality of life in patients receiving chemotherapy versus oral TKI in the third line and beyond setting for advanced non–small-cell …
e21195 Background: The outcomes in advanced non-small cell lung cancer (NSCLC) have
improved due to the availability of more effective systemic & improved supportive care. This …
improved due to the availability of more effective systemic & improved supportive care. This …
Paraparesis in a patient with advanced HIV infection: a diagnostic conundrum
In patients with HIV infection, lower limb weakness is a result of the pathological involvement
of the brain, spinal cord or peripheral nervous system. The pathological process can be …
of the brain, spinal cord or peripheral nervous system. The pathological process can be …
Authors' reply to Shah and Sahu
A John, V Noronha, A Singh, N Menon… - Cancer Research …, 2023 - journals.lww.com
We would like to Shah [1] and Sahu [2] for their valuable inputs with regard to our
article,“Amivantamab: A narrative drug review,” that was published in the previous issue of …
article,“Amivantamab: A narrative drug review,” that was published in the previous issue of …